Application of Viral DNA Quantification for Early
Diagnosis, Monitoring, and Pathophysiological
Analysis of Infectious Diseases
Application of Viral DNA Quantification for Early
Diagnosis, Monitoring, and Pathophysiological
Analysis of Infectious
Diseases
(Quantification of Viral DNA by Multiplex PCR)

Research overview

We perform quantitative analysis of viral DNA using a multiplex real-time PCR assay. Testing can be conducted on a variety of clinical specimens, including blood, urine, cerebrospinal fluid, vesicular fluid, throat swabs, and umbilical cord samples.
Real-time PCR offers high analytical sensitivity and enables the simultaneous early detection of multiple viruses, facilitating evaluation of the association between diverse clinical conditions and viral infections.

Viruses Available for Analysis

・Epstein–Barr virus (EBV)
・Cytomegalovirus (CMV)
・Herpes simplex virus (HSV)
・Varicella-zoster virus (VZV)
・Human herpesvirus 6 (HHV-6)
・Human herpesvirus 7 (HHV-7)
・Human adenovirus (AdV)
・JC virus (JCV)
・BK virus (BKV)
・Human parvovirus B19 (B19V)
・Adeno-associated virus 2 (AAV2)
・Enterovirus genus
・Parechovirus genus

This testing is conducted within a clinical research framework approved by the institutional ethics review board.
Prior to testing:
The referring medical institution must be registered as a collaborating site in this research
program.
Written informed consent for research participation must be obtained from the patient (or legal
guardian).
A completed patient information form must be submitted.

・Epstein–Barr virus (EBV)
・Cytomegalovirus (CMV)
・Herpes simplex virus (HSV)
・Varicella-zoster virus (VZV)
・Human herpesvirus 6 (HHV-6)
・Human herpesvirus 7 (HHV-7)
・Human adenovirus (AdV)
・JC virus (JCV)
・BK virus (BKV)
・Human parvovirus B19 (B19V)
・Adeno-associated virus 2 (AAV2)
・Enterovirus genus
・Parechovirus genus

This testing is conducted within a clinical research framework approved by the institutional ethics review board.
Prior to testing:
The referring medical institution must be registered as a collaborating site in this research program.
Written informed consent for research participation must be obtained from the patient (or legal guardian).
A completed patient information form must be submitted.

Eligibility

Individuals suspected of having symptoms associated with infection by the above-listed viruses and who provide consent to participate in this study.


※This service is available only to medical institutions within Japan.

Individuals suspected of having symptoms associated with infection by the above-listed viruses and who provide consent to participate in this study.




※This service is available only to medical institutions within Japan.